Clinical Trial Update: Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating inhaled liposomal amphotericin B deposition in individuals with chronic pulmonary aspergillosis; the study is not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Aspergillosis

Drugs mentioned

• Liposomal amphotericin B (amphotericin B liposomal)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Chronic Pulmonary Aspergillosis | Phase 1 | Status: NOT_YET_RECRUITING